The designed formulations have not affected the viability of neuroblastoma cells. Furthermore, PC-CdS NPs showed dual properties of disaggregation and inhibition of Tau. Hence, the NPs could be used as potent Tau aggregation inhibitors and can be subjected to several modifications for specific drug delivery owing to their very small size. Here, MAPT is linked to neuroblastoma.